Background/Aim: Supra hemodiafiltration with reinfusion of the endogenous ultrafiltrate (Supra-HFR) is a dialysis technique used to improve uremic toxin removal in the range of the middle molecular weight molecules. Supra-HFR does not require the preparation and online infusion of highpurity dialysis water because it allows the production of an endogenous ultrafiltrate that undergoes detoxification through an adsorbing resin. Patients and Methods: We investigated the ability of Supra-HFR to remove fibroblast growth factor 23 (FGF23), interleukin 6 (IL-6), tumor necrosis factor alpha (TNFalpha), interleukin 8 (IL-8), and transforming growth factor alpha (TGF-alpha) after a single session dialysis in nine patients affected by end stage renal disease (ESRD). The same patients underwent a single session of online hemodiafiltration (OL-HDF) to evaluate possible differences in FGF23 and IL-6 levels. Results: A significant reduction in FGF23 was observed with both Supra-HFR (p=0.001) and OL-HDF. As for TNF-alpha and TGF-alpha, which were measured using Supra-HFR only, their percentage values were significantly lower at the end of dialysis than at the start (p=0. 0028 and p=0.03, respectively). This did not change with post-dialysis rebound. Supra-HFR was found to have no effect on IL-6 and IL-8. Interestingly, the removal rate for FGF23 and IL-6 was similar to that observed with OL-HDF. Conclusion: Supra-HFR was not superior to OL-HDF, with suboptimal convective volume in the removal of the molecules tested, especially FGF23, which is considered a large middle molecular weight uremic toxin.Online hemodiafiltration (OL-HDF) combines diffusive and convective clearance of uremic toxins, thus allowing a markedly enhanced removal of middle molecular weight molecules. For this reason, it has been associated with better cardiovascular outcomes than standard hemodialysis (1-7). However, several pre-conditions need to be met to perform an effective OL-HDF, and not all hemodialysis patients are eligible for this treatment. Two main reasons prevent a broader application of OL-HDF: i) an inadequate vascular access (when blood flow is below 350 ml/min) (7); ii) a water treatment system unable to provide ultrapure water (8). Supra hemodiafiltration with reinfusion of the endogenous ultrafiltrate (Supra-HFR) seems to be a valid alternative, as it has been reported to effectively remove middle molecular weight uremic toxins without albumin loss and without the need of preparing and online infusion of high-purity dialysis fluid. However, despite encouraging data, additional studies are needed to confirm these findings (9-12).The present study evaluated the efficacy of a single session of Supra-HFR in terms of removal of fibroblast growth factor 23 (FGF23) and inflammatory markers in the range of middle molecular weight molecules, namely interleukin 6 (IL-6), tumor necrosis factor alpha (TNF-alpha), interleukin 8 (IL-8), and transforming growth factor alpha (TGF-alpha). After 1769